​Not-for-profit hospitals are under increasing pressure to balance operational efficiency with high-quality patient care. Laboratory testing is critical for diagnosis and treatment, yet outsourcing specialized tests to traditional reference labs often comes with steep markups. Warde Medical Laboratory and Michigan Cotenancy Laboratory (MCL) provide cost-effective laboratory testing that lowers expenses while maintaining diagnostic accuracy. This transforms traditional reference lab services from a recurring cost into a strategic investment for hospitals.

Warde provides specialized testing for cancer markers, toxicology, immunology and allergens, esoteric chemistry, and specialty hematology including flow cytometry, ensuring hospitals can maintain comprehensive diagnostics. MCL’s co-tenancy model enables hospitals to share ownership in the laboratory, providing transparency, influence over operations, and opportunities to benefit from efficiencies that standard vendor contracts do not offer.

​Deliver High-Quality and Cost-Effective Laboratory Testing Across All Services

High-complexity tests often require advanced instruments, specialized reagents, and expert personnel, which traditionally drive-up costs. Warde Medical Laboratory reduces unnecessary overhead by offering services at cost directly to hospital laboratories.

Hospitals gain access to:

• Myeloid Malignancy : Next Generation Sequencing (NGS) panels for diagnosis, monitoring and guiding treatment decisions.
• Toxicology testing: Accurate identification of drugs of abuse, pain management medications, and treatment drug monitoring.
• Immunology and allergen testing: Comprehensive assessments for autoimmune and allergic conditions.
• Esoteric chemistry testing: Advanced assays that support nuanced clinical decisions.

Every test adheres to stringent quality standards. By combining specialized expertise with streamlined operations, hospitals avoid the trade-off between cost and diagnostic reliability.

Operational and Financial Benefits for Hospitals

Partnering with Warde and MCL offers hospitals more than reduced costs; it creates operational and financial advantages that support long-term sustainability.

1. Predictable Costs
Laboratory budgets become more transparent. Hospitals can forecast annual expenses and avoid unexpected markups typical of traditional reference labs.

2. Streamlined Workflows
Direct access to testing services reduces delays in sample processing and report delivery, improving clinical turnaround times.

3. Operational Efficiency
The co-tenancy model fosters collaboration between hospitals and the laboratory, enabling shared input on processes, faster issue resolution, and improved utilization of staff resources.

4. Enhanced Patient Outcomes
Reliable, high-quality testing ensures accurate diagnoses, which supports timely and effective patient care.

5. Strategic Financial Advantages
Partial ownership through MCL aligns financial incentives by providing at cost testing. Hospitals benefit from long-term efficiencies, potential revenue opportunities, and the transformation of lab expenses into strategic assets.

Co-Tenancy Model: A Partnership Approach

MCL allows hospitals to become partial owners of the laboratory, providing them with operational insight and influence. This model gives hospitals a voice in laboratory workflows, test menu development, and quality assurance initiatives. By actively participating in lab operations oversight and guidance, hospitals gain access to efficiencies that would otherwise be lost under traditional service contracts.

Customized client services ensure hospitals receive guidance on test selection, interpretation, and case-specific questions. Warde Medical Laboratory’s experts are available to consult with hospital laboratory directors, clinical pathologists, and physicians, supporting both operational and clinical decision-making.

Implementing Cost-Effective Laboratory Testing Across Hospital Departments

Hospitals often outsource up to 40% of their specialized testing needs, which can include high-complexity oncology panels, toxicology assays, and specialized chemistry tests. Traditional vendor relationships frequently come with rising costs, delays, and limited transparency. By integrating Warde and MCL services, hospitals can:

• Reduce per-test costs by 15–25%.
• Improve turnaround times for high-complexity testing.
• Streamline administrative processes, reducing errors in ordering, billing, and reporting.
• Enhance compliance with regulatory standards and quality benchmarks.

These improvements help hospitals navigate staffing limitations, supply chain pressures, and other operational constraints while maintaining the highest standards of patient care.

Supporting Clinical Accuracy While Reducing Costs

Maintaining diagnostic accuracy is non-negotiable. Warde Medical Laboratory combines robust quality control measures with specialized expertise, ensuring test results are reliable and actionable. By reducing redundant administrative tasks and eliminating hidden costs, hospitals can reinvest resources into patient care initiatives, staff training, and facility improvements.

Cost-effective laboratory testing also supports continuous improvement in clinical workflows which Laboratory directors and pathologists can access consultative services, guidance on complex cases and tailored testing panels and enhancing both efficiency and accuracy.

Why Hospitals Choose Warde Medical Laboratory and MCL

Hospitals seeking a sustainable, cost-conscious approach to reference testing choose Warde and MCL for several reasons:

• Financial transparency: Testing at cost provides predictable budgeting.
• Operational efficiency: Streamlined sample processing and reporting saves time and reduces errors.
• High-quality testing: Specialized assays meet rigorous clinical standards.
• Collaborative co-tenancy model: Hospitals share ownership, gaining influence and long-term financial benefits.
• Improved patient outcomes: Accurate and timely diagnostics support effective treatment.

When partnered with Warde and MCL, hospitals transform laboratory testing from a recurring cost into a strategic advantage, gaining a trusted partner in clinical excellence.

Strategic Advantage for Hospital Leaders

Laboratory directors, CFOs, and clinical pathologists benefit from enhanced oversight, operational transparency, and cost control. Shared ownership encourages alignment between financial and clinical priorities, creating a sustainable model that supports both the hospital’s mission and patient care objectives. Investing in cost-effective laboratory testing empowers hospitals to achieve the following:

• Lower operational costs without compromising quality.
• Optimized workflows for clinicians and laboratory staff.
• Strategic financial planning through long-term lab co-ownership.

This model equips hospital leadership to meet operational, financial and clinical goals simultaneously.

Partner with Warde Medical Laboratory

Not-for-profit hospitals looking to maintain diagnostic accuracy while reducing costs can rely on Warde Medical Laboratory and MCL. Their cost-effective laboratory testing model delivers high quality testing, operational efficiency and financial sustainability.

Contact Warde Medical Laboratory today to explore how this innovative approach can support your hospital’s diagnostic capabilities, optimize resources, and create long-term value.